ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 102817 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 102817; 2) Community: the network communities that were significantly associated with the response to NSC 102817; 3) Molecule: the relationships between components within communities and NSC 102817; 4) MDR: the compounds that were significantly associated with the NSC 102817.

NSC Compound Enrichment Correlation
NSC 760016 (E)-3-(3,5-dimethoxyphenyl)-1-(4-(quinazolin-4-ylamino)phenyl)prop-2-en-1-one 0.0185619722391416 0.27539965
NSC 227279 1,4-Naphthalenedione, 5,8-dihydroxy-2,3-bis(hydroxymethyl)- 0.0209467683758282 0.75489743
NSC 620327 Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester 0.0209467683758282 -0.42109338
NSC 622297 Null 0.0209467683758282 0.49137948
NSC 625502 Antimony, chlorobis(4-morpholinecarbodithioato-S,S')-, 0.0209467683758282 0.64786002
NSC 626162 Discorhabdin C . TFA 0.0209467683758282 0.82703586
NSC 629595 Null 0.0209467683758282 0.69916472
NSC 637921 1H-Pyrazole-1-propanamide, 3,5-diphenyl- N-(4-methoxyphenyl)-4-[(4-methylphenyl)azo]-.beta.-oxo- 0.0209467683758282 -0.48128613
NSC 638241 Null 0.0209467683758282 0.53856542
NSC 639501 Cyclopentanone, 2-pentylidene-5-[(1-piperidinyl)methyl]- hydrochloride 0.0209467683758282 0.59952535
Total:136  Current:75    [First] [Prev] [Next] [Last]